SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ind-Swift Laboratories enters into joint venture to explore opportunities in pharmaceutical field

24 Jun 2022 Evaluate

Ind-Swift Laboratories has entered into a Joint Venture, which shall be operated through a newly incorporated entity viz MJM Remedies, where the Company shall have 75% stake and rest 25% stake shall be held by Ramesh Mehta. The new joint venture will explore the opportunities in the pharmaceutical field. MJM Remedies belongs to pharmaceutical industry.

Ind-Swift Laboratories is global manufacturer of Active Pharmaceutical Ingredients (API), Intermediates and formulations (through group collaboration).

Ind-Swift Labs. Share Price

246.40 11.30 (4.81%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: